SAB Biotherapeutics (SABS) Stock Chart & Stock Price History $1.87 +0.01 (+0.54%) Closing price 06/10/2025 04:00 PM EasternExtended Trading$1.86 -0.01 (-0.53%) As of 06/10/2025 05:42 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SAB Biotherapeutics Stock Price Performance The SAB Biotherapeutics (SABS) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 44.84%, with a year-to-date return of -50.66%. In the past month, the stock has increased 4.47%, reflecting recent market activity. As of the latest close, SAB Biotherapeutics traded at $1.87 with a market cap of $17.37 million and volume of 9,800 shares. Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+3.31%1 Month Performance+4.47%3 Month Performance+23.03%Year-To-Date Performance-50.66%1 Year Performance-44.84% SABS Stock Chart for Wednesday, June, 11, 2025 SABS Chart by TradingView SAB Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/10/2025$1.86$1.87+0.54%$1.89$1.799,800 shs$17.37 million06/09/2025$1.81$1.86+2.76%$1.88$1.799,342 shs$17.28 million06/06/2025$1.82$1.81-0.55%$1.92$1.802,411 shs$16.82 million06/05/2025$1.87$1.82-2.54%$1.92$1.832,930 shs$16.91 million06/04/2025$1.86$1.87+0.40%$1.88$1.7618,280 shs$17.35 million06/03/2025$1.92$1.86-3.12%$1.92$1.8410,363 shs$17.28 million06/02/2025$1.87$1.92+2.67%$1.96$1.8232,906 shs$17.84 million05/30/2025$1.81$1.87+3.31%$2.00$1.8059,305 shs$17.38 million05/29/2025$1.76$1.81+2.84%$1.85$1.7338,746 shs$16.82 million05/28/2025$1.78$1.76-1.12%$1.88$1.7542,343 shs$16.35 million Get the Latest News and Ratings for SABS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/27/2025$1.81$1.78-1.66%$1.88$1.7147,360 shs$16.54 million05/26/2025$1.81$1.81$1.96$1.72217,644 shs$16.82 million05/23/2025$1.86$1.81-2.69%$1.96$1.72217,644 shs$16.82 million05/22/2025$1.71$1.86+8.77%$1.95$1.66317,822 shs$17.28 million05/21/2025$1.84$1.71-7.20%$1.88$1.7127,966 shs$15.89 million05/20/2025$1.80$1.84+2.37%$1.86$1.8017,537 shs$17.12 million05/19/2025$1.85$1.80-2.70%$1.93$1.7735,496 shs$16.73 million05/16/2025$1.94$1.85-4.64%$2.10$1.8428,466 shs$17.19 million05/15/2025$1.85$1.94+4.86%$2.10$1.83320,772 shs$18.02 million05/14/2025$1.88$1.85-1.44%$2.03$1.7647,012 shs$17.19 million05/13/2025$1.98$1.88-5.20%$2.01$1.8623,178 shs$17.44 million05/12/2025$1.79$1.98+10.61%$2.15$1.78143,573 shs$18.39 million Related Companies DOMH Stock Chart FBIO Stock Chart CRIS Stock Chart BOLT Stock Chart MTEM Stock Chart AMGN Stock Chart GILD Stock Chart VRTX Stock Chart REGN Stock Chart ALNY Stock Chart Receive SABS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for SAB Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:SABS) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SAB Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share SAB Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
